scholarly journals Tecnologia assistiva em 3D para pessoas com déficit de função manual por doença de parkinson/Assistive Technology in 3d for people with manual function deficit in parkinson's disease

Author(s):  
Daniela Salgado Amaral ◽  
Danielle Sanguinetti ◽  
Juliana Cassiano Amancio Da Silva ◽  
Priscila Romão Caldas ◽  
José Ângelo Peixoto Da Costa ◽  
...  

A Doença de Parkinson (DP) é uma síndrome neurodegenerativa que se caracteriza essencialmente por déficts motores, incluindo prejuízos nas habilidades manuais, o que interferem no desempenho das atividades cotidianas. Os terapeutas ocupacionais utilizam recursos de Tecnologia Assistiva (TA) para favorecer a autonomia e independência. O uso de TA impressa em 3D é um recurso inovador e possibilita a personalização com baixo custo. O objetivo desta pesquisa é descrever o processo de avaliação e desenvolvimento de produtos de TA em 3D para pessoas com déficit de função manual por Doença de Parkinson. Trata-se de um estudo observacional, descritivo, de corte transversal, do tipo relato de caso. A paciente estudada tinha 61 anos, diagnosticada há 3 anos e era auxiliar administrativa. Apresentava déficit nas habilidades manuais de leve à moderado e as atividades com maior prejuízos funcionais foram: usar colher, varrer casa, usar escova de dentes e manusear a agulha de crochê. A pontuação média de desempenho foi 6,0 e de satisfação 4,5, de acordo com a Medida Canadense de Desempenho Ocupacional, para as atividades citadas. Após escaneamento do membro superior foi impressa em 3D uma adaptação universal para favorecer as atividades do uso da colher, da escova de dente e da agulha de crochê. O recurso proporcionou um melhor desempenho nas atividades e a paciente destacou satisfação com o uso do recurso e serviço utilizados. Dessa forma, A TA impressa em 3D pode ser um recurso eficaz e se faz necessário ampliar os estudos na área. AbstractParkinson's disease (PD) is a neurodegenerative syndrome that is essentially characterized by motor deficit, including impairments in manual skills, which may interfere with the performance of daily activities. Occupational therapists use Assistive Technology (AT) resources to promote autonomy and independence. The use of AT printed in 3D is a resourse innovative and possibility of customization and low cost. The objective of the research is to describe the process of evaluating and developing 3D AT products for people with Parkinson's disease manual function deficit. This is an observational, descriptive, cross-sectional study of the case report type. The patient studied was 61 years old, diagnosed 3 years ago and was an administrative assistant. There were deficits in the manual skills of mild to moderate and the activities with the greatest functional losses were: to use spoon, to sweep house, to use toothbrush, and to handle the crochet needle. The average performance score was 6.0 and satisfaction 4.5, According to the Canadia Measure of Occupational Performance, for the above activities. After scanning the upper limb was printed in 3D universal adaptation with main focus on favoring the activities of using the spoon, toothbrush and crochet needle. The resource favored a better performance in the activities and the patient reported satisfaction with the use of the resource and service used. Assistive technology printed in 3D can be an effective resource, it is necessary to expand the studies in the area.Keywords: Parkinson's disease; Self-Help Devices; Occupational Therapy. Resumen La enfermedad de Parkinson (DP) es un síndrome neurodegenerativo que se caracteriza esencialmente por déficits motores, incluyendo perjuicios en las habilidades manuales, lo que puede interferir en el desempeño de las actividades cotidianas. Los terapeutas ocupacionales utilizan recursos de Tecnología Asistiva (TA) para favorecer la autonomía e independencia. El uso de TA impresa en 3D es un recurso innovador por la posibilidad de la personalización y bajo costo. El objetivo de la investigación es describir el proceso de evaluación y desarrollo de productos de TA en 3D para personas con déficit de función manual por enfermedad de Parkinson. Se trata de un estudio observacional, descriptivo, de corte transversal, del tipo relato de caso. La paciente estudiada tenía 61 años, diagnosticada hace 3 años y era auxiliar administrativo. Presentaba déficit en las habilidades manuales de leve a moderado y las actividades con mayor perjuicios funcionales fueron: usar cuchara, barrer casa, usar cepillo de dientes, y manipular la aguja de crochet. La puntuación media de rendimiento fue de 6,0 y de satisfacción 4,5, de acuerdo con la Medida Canadiense de Desempeño Ocupacional, para las actividades citadas. Después del escaneado del miembro superior se imprimió en 3D adaptación universal con principal foco en favorecer las actividades del uso de la cuchara, del cepillo de dientes y de la aguja de crochet. El recurso favoreció un mejor desempeño en las actividades y la paciente relató satisfacción con el uso del recurso y servicio utilizados. La tecnología asistiva impresa en 3D puede ser un recurso eficaz, se hace necesario ampliar los estudios en el área.Palavras clave: Enfermedad de Parkinson; Dispositivos de Autoayuda; Terapia Ocupacional.

BMJ Open ◽  
2014 ◽  
Vol 4 (1) ◽  
pp. e003976 ◽  
Author(s):  
Eirik Auning ◽  
Veslemøy Krohn Kjærvik ◽  
Per Selnes ◽  
Dag Aarsland ◽  
Astrid Haram ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Taylor Andrew Finseth ◽  
Jessica Louise Hedeman ◽  
Robert Preston Brown ◽  
Kristina I. Johnson ◽  
Matthew Sean Binder ◽  
...  

Introduction. Complementary and alternative medicine (CAM) is frequently used by Parkinson’s disease (PD) patients. We sought to provide information on CAM use and efficacy in PD patients in the Denver metro area with particular attention to cannabis use given its recent change in legal status.Methods. Self-administered surveys on CAM use and efficacy were completed by PD patients identified in clinics and support groups across the Denver metro area between 2012 and 2013.Results. 207 patients (age69±11; 60% male) completed the survey. Responses to individual CAM therapy items showed that 85% of respondents used at least one form of CAM. The most frequently reported CAMs were vitamins (66%), prayer (59%), massage (45%), and relaxation (32%). Self-reported improvement related to the use of CAM was highest for massage, art therapy, music therapy, and cannabis. While only 4.3% of our survey responders reported use of cannabis, it ranked among the most effective CAM therapies.Conclusions. Overall, our cross-sectional study was notable for a high rate of CAM utilization amongst PD patients and high rates of self-reported efficacy across most CAM modalities. Cannabis was rarely used in our population but users reported high efficacy, mainly for nonmotor symptoms.


2017 ◽  
Vol 2017 ◽  
pp. 1-9 ◽  
Author(s):  
Laurie K. Mischley ◽  
Richard C. Lau ◽  
Rachel D. Bennett

Objectives. The goal of this study is to describe modifiable lifestyle variables associated with reduced rate of Parkinson’s disease (PD) progression.Methods. The patient-reported outcomes in PD (PRO-PD) were used as the primary outcome measure, and a food frequency questionnaire (FFQ) was used to assess dietary intake. In this cross-sectional analysis, regression analysis was performed on baseline data to identify the nutritional and pharmacological interventions associated with the rate of PD progression. All analyses were adjusted for age, gender, and years since diagnosis.Results. 1053 individuals with self-reported idiopathic PD were available for analysis. Foods associated with the reduced rate of PD progression included fresh vegetables, fresh fruit, nuts and seeds, nonfried fish, olive oil, wine, coconut oil, fresh herbs, and spices (P<0.05). Foods associated with more rapid PD progression include canned fruits and vegetables, diet and nondiet soda, fried foods, beef, ice cream, yogurt, and cheese (P<0.05). Nutritional supplements coenzyme Q10 and fish oil were associated with reduced PD progression (P=0.026andP=0.019, resp.), and iron supplementation was associated with faster progression (P=0.022).Discussion. These are the first data to provide evidence that targeted nutrition is associated with the rate of PD progression.


2015 ◽  
Vol 2015 ◽  
pp. 1-10 ◽  
Author(s):  
Delia Colombo ◽  
Giovanni Abbruzzese ◽  
Angelo Antonini ◽  
Paolo Barone ◽  
Gilberto Bellia ◽  
...  

Background. The early detection of wearing-off in Parkinson disease (DEEP) observational study demonstrated that women with Parkinson’s disease (PD) carry an increased risk (80.1%) for wearing-off (WO). This post hoc analysis of DEEP study evaluates gender differences on WO and associated phenomena.Methods. Patients on dopaminergic treatment for ≥1 year were included in this multicenter observational cross-sectional study. In a single visit, WO was diagnosed based on neurologist assessment as well as the use of the 19-item wearing-off questionnaire (WOQ-19); WO was defined for scores ≥2. Post hoc analyses were conducted to investigate gender difference for demographic and clinical features with respect to WO.Results. Of 617 patients enrolled, 236 were women and 381 were men. Prevalence of WO was higher among women, according to both neurologists’ judgment (61.9% versus 53.8%,P=0.045) and the WOQ-19 analysis (72.5% versus 64.0%,P=0.034). In patients with WO (WOQ-19), women experienced ≥1 motor symptom in 72.5% versus 64.0% in men and ≥1 nonmotor symptom in 44.5% versus 36.7%, in men.Conclusions. Our results suggest WO as more common among women, for both motor and nonmotor symptoms. Prospective studies are warranted to investigate this potential gender-effect.


Author(s):  
Arun Kurupath ◽  
Praveen Arathil ◽  
Rahul Bansal

Introduction: Parkinson’s Disease (PD) is a progressive neurodegenerative disorder where the individual over time needs more and more assistance from their caregivers to carry on their life and that causes increasing burden on the caregiver. The burden for the caregiver is affecting them physically, mentally and also on a socioeconomic level. Aim: To examine the factors related to caregiver burden in caregivers of Parkinson’s patients. Materials and Methods: This was a cross-sectional study conducted in Parkinson’s clinic of a Tertiary Care Hospital of Kochi, on 100 Parkinsonism patients and their respective caregivers. Patients were assessed using the Unified PD Rating Scale (UPDRS), Hoehn and Yahr Scale (H&Y) and Mini-Mental State Examination (MMSE). Caregivers were assessed using Zerit’s Caregiver Burden inventory (CBI). Semi structured questionnaire was administered for socio-demographic details. Non parametric tests were done to examine the correlation among various variables. Results: Among the patients and caregivers, mean age was 70.65±7.30 and 67.31±8.56, respectively. Among the patient’s majority were males (n=74) while among caregivers, majority were females (n=73). Mean duration of disease was 6.79±2.68 years, mean caregiver burden score was 65.05±21.79, mean UPDRS score was 21.89±8.74 and had significant positive correlation with caregiver burden. Mean MMSE score was 17.19±4.91. The disease duration and UPDRS score had a significant positive correlation with caregiver burden score. MMSE score had significant negative correlation with caregiver burden score. Conclusion: This study concludes that a patient’s Parkinsonism related disability accounts for majority of caregiver burden. An early identification of factors contributing to stress in caregivers will help to avoid its persistency leading to a better insight in the caregiving role and thus in-patient care.


Gerontology ◽  
2018 ◽  
Vol 65 (3) ◽  
pp. 216-228 ◽  
Author(s):  
Marina Peball ◽  
Philipp Mahlknecht ◽  
Mario Werkmann ◽  
Kathrin Marini ◽  
Franziska Murr ◽  
...  

Background: Sarcopenia and frailty are found in up to one-third of the general elderly population. Both are associated with major adverse health outcomes such as nursing home placement, disability, decreased quality of life, and death. Data on the frequency of both syndromes in Parkinson’s disease (PD), however, are very limited. Objective: We aimed to screen for sarcopenia and frailty in PD patients and to assess potential associations of both geriatric syndromes with demographic and clinical parameters as well as quality of life. Methods: In this observational, cross-sectional study, we included 104 PD patients from a tertiary center and 330 non-PD controls from a population-based cohort aged > 65 years. All groups were screened for sarcopenia using the SARC-F score and for frailty using the Clinical Frailty Scale of the Canadian Study of Health and Aging (CSHA CFS). Prevalence rates of sarcopenia and frailty were also assessed in 18 PD patients from a population-based cohort aged > 65 years. Moreover, PD patients from the tertiary center were evaluated for motor and non-motor symptoms, quality of life, and dependency. Results: The prevalence of sarcopenia was 55.8% (95% CI: 46.2–64.9%) in PD patients from the tertiary center and 8.2% (5.7–11.7%; p < 0.001) in non-PD controls. Frailty was detected in 35.6% (27.0–45.2%) and 5.2% (3.2–8.1%; p < 0.001). Prevalence rates for sarcopenia and frailty were 33.3% (16.1–56.4%; p = 0.004) and 22.2% (8.5–45.8%; p = 0.017) in the community-based PD sample. Both sarcopenia and frailty were significantly associated with longer disease duration, higher motor impairment, higher Hoehn and Yahr stages, decreased quality of life, higher frequency of falls, a higher non-motor symptom burden, institutionalization, and higher care levels in PD patients from a tertiary center compared to not affected PD patients (all p < 0.05). Conclusions: Both frailty and sarcopenia are more common in PD patients than in the general community and are associated with a more adverse course of the disease. Future studies should look into underlying risk factors for the occurrence of sarcopenia and frailty in PD patients and into adequate management to prevent and mitigate them.


2020 ◽  
Vol 10 (9) ◽  
pp. 588
Author(s):  
Elena Cecilia Rosca ◽  
Mihaela Simu

The aim of the present systematic review was to examine the evidence on the accuracy and psychometric properties of the Parkinson’s Disease-Cognitive Rating Scale (PD-CRS) for evaluating the presence of cognitive impairment in patients with Parkinson’s disease (PD) as well as to highlight the quality and quantity of research available on the use of the PD-CRS in this population. We searched four databases from inception until July 2020. Eight studies, published between 2008 and 2020, met the inclusion criteria: One cross-sectional study in which participants were assessed with the index test (PD-CRS) and a reference standard diagnostic assessment, in accordance with the Level II criteria of the International Parkinson and Movement Disorder Society (MDS); one case-control study comparing the PD-CRS to an extensive battery of tests (i.e., MDS Level II diagnosis); and six studies comparing the PD-CRS to other short cognitive batteries. In patients with Parkinson’s disease, the PD-CRS test provides information about cortical and sub-cortical cognitive functions. Even if it demonstrated good psychometric properties, the results regarding the optimal threshold for detecting mild cognitive impairment and dementia in PD are somewhat inconsistent. Further cross-sectional studies are necessary to examine the optimum cut-off score for detecting cognitive dysfunction in PD patients.


Sign in / Sign up

Export Citation Format

Share Document